Supply@ME Capital Reports Interim Losses and Going Concern Uncertainties

Supply@ME’s half-year numbers: small revenue, slimmer losses, and a tight cash position

Supply@ME Capital has finally posted its H1 2025 unaudited results and, with the FY24 Annual Report now out (13 October 2025), the Company will apply to lift its trading suspension. The topline is modest revenue growth, a narrower operating loss, but a very tight balance sheet and clear going concern uncertainties.

• Revenue rose to £87,000 in H1 2025 from £39,000 in H1 2024.
• Adjusted operating loss improved to £595,000 from £1,339,000.
• Loss before tax narrowed to £841,000 from £1,468,000.
• Cash was £17,000 at 30 June 2025; net current liabilities £4.4 million.
• Net liabilities increased to £5.277 million (31 December 2024: £4.246 million).
• Going concern flagged with material uncertainties tied to revenue timing and the Nuburu facility.
• Inventory monetised to date: £4.5 million as at 30 September 2025.
• Pipeline with signed letters of interest/term sheets: £87.3 million as at 30 September 2025, but heavily concentrated.

Key figures investors should know

Metric	H1 2025	H1 2024
Revenue	£87,000	£39,000
Adjusted operating loss	£595,000	£1,339,000
Loss before tax	£841,000	£1,468,000
Cash and cash equivalents (30 June)	£17,000	£404,000
Net liabilities (30 June)	£5,277,000	£2,792,000

Note: Adjusted operating loss excludes impairment charges and fair value adjustments. Inventory monetisation revenues are recognised under IFRS 15 and split across origination fees, platform usage fees, and IM service fees.

Funding lifeline and dilution risk: the Nuburu on-demand facility

SYME’s cash pressures in 2024 – exacerbated by non-performance under TAG’s £3.5 million Top-Up Shareholder Loan Agreement – led to a new US$5.15 million on-demand convertible facility with Nuburu Inc. signed in March 2025, then amended in June and August 2025.

• Cash received in H1 2025: US$652,000 (equivalent to £475,000). As at the date of the announcement: US$2,952,000 received, US$2,198,000 due on or before 31 October 2025.
• Conversion terms: fixed at £0.00003 per share, with 1 warrant for every 2 shares issued. Warrant exercise price is £0.000039, and can be cashless.
• If fully converted, Nuburu would have a controlling interest in the Group.
• Approvals required by 30 June 2026 to repay via conversion rather than cash. If not obtained, Nuburu can demand cash and take security over IP and certain receivables.
• Related party: Nuburu is a related party as Alessandro Zamboni is Executive Chairman of Nuburu.

Why it matters: this facility is the bridge to keep SYME operating while it tries to scale IM transactions. The risk is twofold: timing of the final US$2.198 million, and shareholder/regulatory approvals for conversion. If conversion cannot happen, cash repayment could be required from a business with £17,000 in cash at the half-year. On the flip side, if the facility completes and converts, dilution will be significant, but the going concern pressure would ease.

Operational progress: monetisation in the market, pipeline refined and concentrated

SYME reports £4.5 million of inventory monetised to date via “first purchase” transactions as at 30 September 2025. The pipeline reported is now stricter – only client companies with signed letters of interest or term sheets are counted.

• Pipeline: £87.3 million as at 30 September 2025, versus £125.2 million at 16 December 2024 and £31.3 million as at 19 April 2024.
• Concentration: approximately 95% of the pipeline comes from three clients; four clients in total are included.
• Largest prospective client is 35% of the pipeline, down from 66% in December 2024.

Funding channels remain in development. The IM Bond structure via an SFE-owned stock company saw €3.5 million subscribed by a global asset manager, funding two transactions in December 2024 and January 2025 with £2.4 million of first purchase value. Discussions continue to expand this structure and support single-name transactions.

The Italian neo banking alliance is on hold due to potential acquisition activity, but not terminated. The BBPM white-label programme is working through structural points, aiming to avoid needing a specific remarketer per transaction – delays were compounded by BBPM’s proposed acquisition situation. Staff attrition has been higher than normal, with management looking to partner for specialist data and analysis rather than backfill all roles.

Costs, impairments and what’s behind the slimmer operating loss

The adjusted operating loss improved by £744,000 year-on-year to £595,000, helped by cost control, favourable FX, and higher other operating income.

• Other operating income: £179,000, primarily interest on late TAG funding – but note a £178,000 impairment against TAG late interest receivable was recognised in H1 2025 following TAG entering an Italian liquidation process on 7 August 2025.
• Intangible impairment: £1,000 against the internally developed IM Platform, reflecting continuing uncertainty in timing and growth of platform-driven cash flows.

This is disciplined housekeeping under pressure. But it is still housekeeping – the real pivot will be consistent conversion of pipeline to monetised inventory at scale.

Balance sheet reality check and going concern uncertainties

Cash fell to £17,000 and net current liabilities were £4.405 million at 30 June 2025. Trade and other payables rose to £4.954 million, including £2.184 million of social security and other payroll taxes. Long-term borrowings reduced modestly to £278,000, while new current borrowings of £475,000 reflect cash received under the Nuburu facility.

The Board highlights three material uncertainties to going concern:

• Timing and growth of inventory monetisation revenue streams.
• Receipt of the remaining Nuburu tranches on time and in full.
• Obtaining shareholder and regulatory approvals by 30 June 2026 to allow conversion of the Nuburu facility into equity.

What could help medium term: proposed new Italian legislation to enable inventory securitisation, broadening the routes to fund warehouse goods and non-registered movable assets. That could pull more funders into the asset class. But it is prospective, not in the numbers today.

What I think this means for shareholders

There are two clocks to watch. The first is immediate: the final US$2.198 million Nuburu tranche due by 31 October 2025 and the application to lift the suspension now the results are out. The second is structural: approvals for conversion by 30 June 2026 and, critically, the conversion of pipeline into fee-generating IM transactions at scale.

On the positive side, operating losses have been cut, the IM Bond channel is functioning, the pipeline is now reported on a firmer basis, and inventory monetised has climbed to £4.5 million. On the negative side, the balance sheet is stretched, payables are elevated, the pipeline is concentrated in a handful of clients, and the going concern hinges on both funding and approvals.

In short, this remains a high-risk, high-operational-leverage story. If funding lands and conversion approvals are secured, SYME can keep building a track record and pursue scale. If either slips, the cash position leaves little margin for error.

Where to dig deeper

If you want the full technical detail, the FY24 Annual Report and Accounts published on 13 October 2025 is available here: Supply@ME results and reports.